dw, with the rapid advancement in technology, probably a

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28 dw #3401
134
dw, with the rapid advancement in technology, probably a geometric rise in "unintended consequences".

That is my thought with genetically engineered mosquito's. The male GE will mate with a female and kill it. What about the balance of nature? Little bugs are the basis of life for birds, frogs, snakes, etc. And they are food for the next level, etc.. Now the have GE salmon that will kill nature's salmon. And on and on and on.

I believe that a new world order of some sort could be very beneficial for mankind. , we are destroying the planet. But, the dudes in charge now are the ones destroying it. The BP oil spill- oils companies, Fukishima--General Electric. water in Flint, Michigan--local government. Monsanto 'Roundup is positioning the soil, fracking is ruining ground water. The Ogalalla underwater reservoir is being deplete by farmers, And all these groups basically run the government with campaign donations or even more directly, like the USGA filled with big food an fertilizer company's past employees, etc.

At the Oscars last night many were decrying gun violence and the NRA, yet many used a gun or fake gun in the movie they were in, OMG. Reruns of Criminal Minds are on almost nightly, OMG.

Or world is so screwed up. Government puts endless regulation on the healthcare system, making it very expensive and keeping new competition out, then that same government wants to solve the problem with them taking over and handing the oligopoly a monopoly with even more red tape., OMG

Government is evil because each entity wants to make it's little niche of government a little bigger, giving them more power. You end up with the current mess. Their answer, is a bigger government, a NWO, OMG for the future of the world.

End of rant.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

BIC's Latest Voting Rights and Shares Disclosure Details

Updated Category News Views 180

Key Disclosure on Voting Rights and Shares As a reputable leader in stationery and consumer products, BIC is committed to transparency. Recently, they provided crucial insights into their corporate structure, particularly regarding the total number of voting rights and shares. This disclosure highlights the ongoing dedication towards maintaining clear communication with...

Continue Reading
AGCO Showcase: Innovations and Autonomy for 2026 Farmers

Updated Category News Views 212

AGCO (NYSE: AGCO) is strutting its stuff at the 2026 Commodity Classic in San Antonio from February 25-27. Picture this: over 24,000 square feet jam-packed with cutting-edge agricultural machinery aimed at farmers who want to boost their operations. Yeah, the buzz is all about showcasing their big guns like Fendt®, Massey Ferguson®, and PTx™—but dig deeper into...

Continue Reading
Revolutionizing Healthcare Marketing with Ignite Pulse Solutions

Updated Category News Views 371

Revolutionizing Healthcare Marketing with Ignite Pulse Solutions In the shifting landscape of healthcare marketing, WebMD Ignite introduces a significant enhancement aimed at assisting health systems in thriving amidst the challenges posed by AI and budget constraints. Presenting Ignite Pulse™, this groundbreaking solution offers a comprehensive growth strategy designed...

Continue Reading
Eupraxia Pharmaceuticals Welcomes New Leaders to Innovate Growth

Updated Category News Views 190

Eupraxia Pharmaceuticals Expands Leadership Team Eupraxia Pharmaceuticals Inc. (TSX: EPRX) (NASDAQ: EPRX), known for its innovative approaches in drug delivery technology, has recently announced two significant additions to its leadership. Dr. Amanda Malone has been appointed as the Chief Operating and Scientific Officer, alongside Dr. Rahul Sarugaser as Executive Vice...

Continue Reading
Illumina Enhances Oncology Solutions for Better Cancer Care

Updated Category News Views 186

Illumina's Latest Developments in Oncology In an exciting development, Illumina Inc. (NASDAQ: ILMN) has announced a significant expansion in its clinical oncology portfolio. This move aims to set a new standard of care and enhance access to precision therapies through advanced genomic profiling. Following the recent FDA approval of Illumina's TSO Comprehensive test, the...

Continue Reading